0001567619-21-016869.txt : 20210908 0001567619-21-016869.hdr.sgml : 20210908 20210908204816 ACCESSION NUMBER: 0001567619-21-016869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210907 FILED AS OF DATE: 20210908 DATE AS OF CHANGE: 20210908 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Du Ying CENTRAL INDEX KEY: 0001731790 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38205 FILM NUMBER: 211243346 MAIL ADDRESS: STREET 1: C/O ZAID LAB LIMITED STREET 2: 4560 JINKE ROAD, BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Zai Lab Ltd CENTRAL INDEX KEY: 0001704292 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 BUSINESS PHONE: 862161632588 MAIL ADDRESS: STREET 1: 4560 JINKE ROAD STREET 2: BLDG. 1, 4F, PUDONG CITY: SHANGHAI STATE: F4 ZIP: 201210 4 1 doc1.xml FORM 4 X0306 4 2021-09-07 0 0001704292 Zai Lab Ltd ZLAB 0001731790 Du Ying C/O ZAI LAB LIMITED 4560 JINKE ROAD, BLDG 1, 4TH FLOOR PUDONG, SHANGHAI F4 201210 CHINA 1 1 0 0 Chairwoman & CEO Ordinary Shares 2021-09-07 4 S 0 382 143.25 D 1038056 D Ordinary Shares 2021-09-07 4 S 0 1161 146.73 D 1036895 D Ordinary Shares 2021-09-07 4 S 0 86 147.90 D 1036809 D Ordinary Shares 2021-09-07 4 S 0 649 148.97 D 1036160 D Ordinary Shares 2021-09-07 4 S 0 3776 150.05 D 1032384 D Ordinary Shares 2021-09-07 4 S 0 20252 151.10 D 1012132 D Ordinary Shares 2021-09-07 4 S 0 3300 151.83 D 1008832 D Ordinary Shares 2021-09-07 4 S 0 179 152.75 D 1008653 D The reported transaction was effected pursuant to a sales plan adopted by the Reporting Person, dated March 3, 2021, expires December 31, 2021 and is intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. Reflects a weighted average sale price of $146.73 per share, at prices ranging from $146.41 to $147.32 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Reflects a weighted average sale price of $147.90 per share, at prices ranging from $147.50 to $148.04 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Reflects a weighted average sale price of $148.97 per share, at prices ranging from $148.52 to $149.37 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Reflects a weighted average sale price of $150.05 per share, at prices ranging from $149.57 to $150.53 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Reflects a weighted average sale price of $151.10 per share, at prices ranging from $150.58 to $151.57 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Reflects a weighted average sale price of $151.83 per share, at prices ranging from $151.58 to $152.53 per share. The Reporting Person will provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. ***The Power of Attorney given by Ms. Du was previously filed with the U.S. Securities and Exchange Commission on January 4, 2021 as an exhibit to the Form 3 filed by Ms. Du." /s/ Bruce A. Blefeld, Attorney-in-Fact 2021-09-08